Obesity drugs still out-earn OpenAI and Anthropic combined at $71B a year
HealthcareAIGuy · x · 2026-10-21
A viral comparison: Ozempic and Mounjaro generated roughly $71B last year — about 4x the combined revenue of OpenAI and Anthropic — while only 2% of people with obesity worldwide take these drugs. The author asks how this gap will play out as AI labs scale revenue.
More from AGI Musings
- Polymarket puts just 7% odds on OpenAI pausing AI training this year — Polymarket · 2026-10-21
- Daniel Lemire: AI-generated papers are exposing academia's 'Profzi scheme' — lemire · 2026-10-21
- Universities block thesis downloads while each dissertation averages barely a handful of lifetime reads — generativist · 2026-10-21
- Berkeley wins Schmidt Sciences HAVI grant to decode whale and parrot communication with AI — begusgasper · 2026-10-21
- 3Blue1Brown says he'll keep making videos long after LLMs can generate clear explainers — 3blue1brown · 2026-10-21
- Talos researcher: AI agent attacks today are loud pentests — quiet swarms are the real threat — matthew_d_green · 2026-10-21